Search

everythinglearnresearchcommunity

for

Search:↓

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Clonally expanded CD8+ T cells cause alopecia areata.

Granulocyte colony stimulating factor helps heal wounds without scars.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

The framework suggests sun protection, retinoids, and antioxidants to improve skin longevity.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

New treatments focusing on immune pathways show promise for stubborn hair loss.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Iron balance is crucial for skin health, affecting conditions like psoriasis and hair loss.

Stem cell-derived exosomes could be a promising new treatment for hair regrowth.

Biological factors are crucial for developing new hair restoration treatments.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Gynostemma pentaphyllum and its component damulin B could help hair grow by activating certain cell pathways.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Fibroblast-derived growth factors and exosomes can significantly improve skin aging.